Key result
Imaging brown adipose tissue with 125I-BMIPP-SPECT/CT yielded more physiologically relevant data than 18FDG-PET/CT in a preclinical mouse model.
Why the study?
18FDG-PET/CT is traditionally used to image brown adipose tissue activity, but its primary energy source is intracellular fatty acids rather than glucose, making fatty acid analogues like BMIPP potential alternatives.
Does 125I-BMIPP-SPECT/CT provide more physiologically relevant data than 18FDG-PET/CT for imaging metabolically active brown adipose tissue in a preclinical model?
Does 125I-BMIPP-SPECT/CT provide more physiologically relevant data than 18FDG-PET/CT for imaging metabolically active brown adipose tissue in a preclinical model?
Imaging brown adipose tissue with the radioiodinated fatty acid analogue BMIPP yields more physiologically relevant data regarding metabolic rate than traditional 18FDG-PET/CT in a preclinical model.
BMIPP-SPECT/CT may enable fatty acid-based BAT imaging in models; leaves open clinical translation for metabolic research.
Obesity is a leading cause of preventable death and morbidity. To elucidate the mechanisms connecting metabolically active brown adipose tissue (BAT) and metabolic health may provide insights into methods of treatment for obesity-related conditions. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18FDG-PET/CT) is traditionally used to image human BAT activity. However, the primary energy source of BAT is derived from intracellular fatty acids and not glucose. Beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) is a fatty acid analogue amenable to in vivo imaging by single photon emission computed tomography/CT (SPECT/CT) when radiolabeled with iodine isotopes. In this study, we compare the use of 18FDG-PET/CT and 125I-BMIPP-SPECT/CT for fat imaging to ascertain whether BMIPP is a more robust candidate for the non-invasive evaluation of metabolically active adipose depots. Interscapular BAT, inguinal white adipose tissue (iWAT), and gonadal white adipose tissue (gWAT) uptake of 18FDG and 125I-BMIPP was quantified in mice following treatment with the BAT-stimulating drug CL-316,243 or saline vehicle control. After CL-316,243 treatment, uptake of both radiotracers increased in BAT and iWAT. The standard uptake value (SUVmean) for 18FDG and 125I-BMIPP significantly correlated in these depots, although uptake of 125I-BMIPP in BAT and iWAT more closely mimicked the fold-change in metabolic rate as measured by an extracellular flux analyzer. Herein, we find that imaging BAT with the radioiodinated fatty acid analogue BMIPP yields more physiologically relevant data than 18FDG-PET/CT, and its conventional use may be a pivotal tool for evaluating BAT in both mice and humans.
No takes yet. Share an insight, caveat, or question.
Frankl et al. (2022) studied Brown adipose tissue imaging. 125I-BMIPP-SPECT/CT vs. 18FDG-PET/CT was evaluated on Radiotracer uptake in interscapular BAT, inguinal white adipose tissue, and gonadal white adipose tissue. Imaging brown adipose tissue with 125I-BMIPP-SPECT/CT yielded more physiologically relevant data than 18FDG-PET/CT in a preclinical mouse model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: